SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-034072
Filing Date
2024-02-13
Accepted
2024-02-13 18:41:55
Documents
2
Group Members
CHRISTOPHER HOLLOWOODROEL BULTHUISSYNCONA HOLDINGS LTDSYNCONA INVESTMENT MANAGEMENT LTDSYNCONA LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d783202dsc13ga.htm SC 13G/A 128290
2 EX-99.1 d783202dex991.htm EX-99.1 7597
  Complete submission text file 0001193125-24-034072.txt   137857
Mailing Address FRANCES HOUSE, PO BOX 273 SIR WILLIAM PLACE ST PETER PORT, GUERNSEY X0 GY1 3 RD
Business Address 3RD FLOOR, ARNOLD HOUSE PO BOX 273, ST JULIAN'S AVENUE ST PETER PORT Y7 GY1 3RD 001442039817909
Syncona Portfolio Ltd (Filed by) CIK: 0001725042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y7 | Fiscal Year End: 0331
Type: SC 13G/A

Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Subject) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90550 | Film No.: 24630840
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)